Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5622209 | Thrombosis Research | 2016 | 7 Pages |
Abstract
Minigene I incorporating the IVS-8 deletion showed two products: a normal splicing product and the unspliced product. Minigene II incorporating the Ex-9 deletion only produced the unspliced product. The established γâ²409ÎA-CHO cells secreted variant fibrinogen more effectively than normal fibrinogen. Therefore, the aberrant splicing products derived from the IVS-8 deletion cause hypofibrinogenemia most likely due to nonsense-mediated mRNA decay and the partial production of normal γA- and γâ²-chains; moreover, the Ex-9 deletion causes hypodysfibrinogenemia due to the absence of normal γA- and γâ²-chain production (hypofibrinogenemia) and augmented aberrant γâ²-chain production (dysfibrinogenemia).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Saki Mukai, Kazuhiro Nagata, Minami Ikeda, Shinpei Arai, Mitsutoshi Sugano, Takayuki Honda, Nobuo Okumura,